ESG: from reporting obligation to opportunity for value creation
Insights from Holland Capital and Deloitte’s webinar
Amsterdam, 21st of March 2025 – On March 6, in partnership with Deloitte, we organized an engaging and inspiring ESG webinar for our portfolio companies. During the session, we explored the impact of ESG by discussing both regulations and, more importantly, opportunities for value creation. Deloitte shared valuable insights on how companies should approach ESG not just as a compliance issue, but rather as a possibility for growth and value creation.
More and more companies are facing ESG (Environmental, Social & Governance) reporting requirements. What could feel like an obligation actually offers opportunities for innovation and value creation. During the recent ESG webinar, organized by Holland Capital in collaboration with Deloitte, participating portfolio companies gained valuable insights into ESG and its impact on their organization. Below we share the key learnings from this webinar.
ESG: Why is it relevant?
ESG is not a trend, but has long been an essential aspect of how companies operate. Finding the right balance between a company’s impact on people, the environment and its (financial) performance is something the United Nations already pointed out 40 years ago. Companies should see sustainability not only as an obligation to comply with regulations, but also as an opportunity to become more efficient, transparent and future-proof.
- Environmental: How does your company affect the environment? Consider carbon emissions, energy consumption and circular economy.
- Social (social): How do you interact with employees, customers and society? Think diversity, inclusion and working conditions.
- Governance (governance): How are policy and strategy set up to conduct business ethically?
A key message from the webinar: ESG is not only relevant for large corporates, but also for SMEs. Many companies are already implementing sustainable strategies and activities, perhaps without being aware of it being labeled as sustainable. By giving this structure, entrepreneurs can leverage ESG as a competitive advantage.
Laws and regulations: What do you need to know?
An important topic discussed during the webinar was the Corporate Sustainability Reporting Directive (CSRD). A brief update on the recently proposed changes:
- Companies with more than 1,000 employees will not fall under the obligation until later.
- Large companies continue to impose ESG reporting requirements on their suppliers and supply chain partners.
- Transparency about ESG performance is becoming increasingly important to various stakeholders, such as banks, investors and potential employees.
For entrepreneurs, this means that even if their company is not (or no longer) directly in scope of the the CSRD, they could indirectly be requested to share ESG information with partners and investors. This also applies to Holland Capital: our obligations towards investors and from complying with the Sustainable Finance Disclosure Regulation (SFDR) requires our portfolio companies to provide ESG data. Those insights can be valuable and provide benefits, or identify necessary actions.
Materiality: Where do you start?
An important concept within ESG is materiality – or, in other words, which ESG topics are most relevant to your company? Materiality can be viewed from two perspectives, so-called double materiality:
- Financial impact: Which ESG topics affect profitability?
- Social impact: What impact does your company have on people and the environment?
- A structured approach helps companies not only comply with regulations, but also achieve strategic benefits.
Conclusion: ESG as a catalyst for growth?
The main message from the webinar: don’t see ESG as a burden, but as an opportunity for growth, efficiency and value creation. By understanding key material themes and responding to sustainability developments, companies can not only comply with regulations, but also gain strategic advantages.
Moreover, many companies are already engaged in sustainable initiatives and strategies – they might haven’t yet labeled them as ESG.
Holland Venture maakt fusie HighCare en AmbuCare mogelijk door groeikapitaal
Amsterdam, 1 december 2011 - Participatiemaatschappij Holland Venture investeert in AmbuCare om zo een fusie te bewerkstelligen tussen portefeuille onderneming HighCare en de sterke organisatie voor onder meer flexibel ambulancepersoneel. De financiële injectie van...
Holland Venture wordt actief in reissector door investering in Institute of Travel
Amsterdam, 31 oktober 2011 - Participatiemaatschappij Holland Venture investeert in Institute of Travel (IOT), een reisorganisatie die zich met een onderscheidend aanbod richt op nichemarkten. IOT heeft een overwegend seniore doelgroep en past daarmee uitstekend...
Holland Venture onderschrijft de Principles for Responsible Investment (PRI) van de Verenigde Naties
Amsterdam, 1 juni 2011 - Holland Venture Partners BV onderschrijft de ‘Principles for Responsible Investment’ van de Verenigde Naties en is als ‘PRI Signatory’ erkend. PRI geeft investeerders richtlijnen en handvatten om in het investeringsproces de juiste aandacht te...
Investering Holland Venture versnelt groeistrategie Interhealth
Amsterdam, 1 augustus 2010 - Participatiemaatschappij Holland Venture investeert in de innovatieve zorgonderneming Interhealth . Met deze investering kan Interhealth haar ambitieuze groeistrategie - de GGZ efficiënter én beter betaalbaar aanbieden - versneld gaan...
HighCare breidt haar dienstverleningspakket uit met eigen uitzendbureau
Amsterdam, 1 juli 2010 - HighCare, Human Capital Partner voor de medische- en zorgsector, breidt haar dienstverleningspakket per 1 juli 2010 uit met ‘HighCare Uitzendbureau’. Door het opzetten van dit uitzendbureau kan HighCare naast de levering van zorgprofessionals...
Holland Venture investeert in groei van medisch detacheringspecialist High Care
Amsterdam, 12 januari 2010 - Participatiemaatschappij Holland Venture investeert per 12 januari 2010 een significant bedrag in detacheringspecialist High Care, een bedrijf dat actief is in de medische sector. Met deze investering zal High Care haar groei versneld...
Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 3119411
Düsseldorf
Königsallee 42
40212 Düsseldorf
+49 (0) 211 96290120
Contact
info@hollandcapital.nl